Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2020

NEXT STORY
VBL Therapeutics Announces Appointment of Marc Kozin as Vice Chairman of Board of Directors
PREV STORY
MediciNova Announces Positive Findings on MN-001 (tipelukast) in Acute Liver Injury Model to be Presented at The Liver Meeting Digital Experience™ 2020
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Osiris Therapeutics, Inc. Announces Peer-Reviewed Publication Comparing the Efficacy of Viable Cryopreserved Placental Membranes to Human Fibroblast-Derived Dermal Substitute in the Treatment of Chronic Diabetic Foot Ulcers (DFUs) in a Multicenter Randomized Clinical Trial

COLUMBIA, Md., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative ...

author_avatar
NASDAQ Market News

Oxford Biomedica plc: Board Changes

author_avatar
NASDAQ Market News

Wound Debridement Market Research Report by Product, by Wound Type, by End User, by State – United States Forecast to 2026 – Cumulative Impact of COVID-19

author_avatar
NASDAQ Market News